Physician profile
Ivey Caison
NPI 1841985595
$684.60
in general payments reported to CMS, 2019-2025
12 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $43.95 · 2024: $251 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643 · Entertainment: $41.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.08 |
| Entertainment | $41.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $159.48 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $112.42 | 2025 | |
| Sun Pharmaceutical Industries INC. | $63.77 | 2024-2025 | |
| Oyster Point Pharma, INC. | $59.98 | 2023-2024 | Tyrvaya |
| Alcon Vision LLC | $56.29 | 2024-2025 | Rocklatan, Total30 |
| Bausch & Lomb Americas INC. | $56.19 | 2023-2025 | Miebo, Infuse |
| Optos, INC. | $41.52 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Mallinckrodt Hospital Products INC. | $39.86 | 2024-2025 | Acthar |
| Abbvie INC. | $32.08 | 2024 | |
| Harrow Eye, LLC | $30.24 | 2025 | Vevye |
| Ani Pharmaceuticals, INC. | $17.22 | 2024 | Purified Cortrophin Gel |
| Johnson & Johnson Vision Care, INC. | $15.55 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivey Caison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.